Cite
HARVARD Citation
, . et al. (2018). Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Vaccine. 36 (5), pp. 668-674. [Online].